These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25240929)
1. The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR trafficking. Doller A; Badawi A; Schmid T; Brauss T; Pleli T; zu Heringdorf DM; Piiper A; Pfeilschifter J; Eberhardt W Exp Cell Res; 2015 Jan; 330(1):66-80. PubMed ID: 25240929 [TBL] [Abstract][Full Text] [Related]
2. HuR translocation to the cytoplasm of cancer cells in actin-independent manner. Habiba U; Kuroshima T; Yanagawa-Matsuda A; Kitamura T; Chowdhury A; Jehung JP; Hossain E; Sano H; Kitagawa Y; Shindoh M; Higashino F Exp Cell Res; 2018 Aug; 369(2):218-225. PubMed ID: 29807023 [TBL] [Abstract][Full Text] [Related]
3. RNA-dependent association with myosin IIA promotes F-actin-guided trafficking of the ELAV-like protein HuR to polysomes. Doller A; Schulz S; Pfeilschifter J; Eberhardt W Nucleic Acids Res; 2013 Oct; 41(19):9152-67. PubMed ID: 23921630 [TBL] [Abstract][Full Text] [Related]
4. High-constitutive HuR phosphorylation at Ser 318 by PKC{delta} propagates tumor relevant functions in colon carcinoma cells. Doller A; Winkler C; Azrilian I; Schulz S; Hartmann S; Pfeilschifter J; Eberhardt W Carcinogenesis; 2011 May; 32(5):676-85. PubMed ID: 21310943 [TBL] [Abstract][Full Text] [Related]
5. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Murata K; Sakamoto A Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747 [TBL] [Abstract][Full Text] [Related]
6. Regulation of intracellular trafficking and secretion of adiponectin by myosin II. Bedi D; Dennis JC; Morrison EE; Braden TD; Judd RL Biochem Biophys Res Commun; 2017 Aug; 490(2):202-208. PubMed ID: 28606474 [TBL] [Abstract][Full Text] [Related]
7. HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer. Zhu H; Berkova Z; Mathur R; Sehgal L; Khashab T; Tao RH; Ao X; Feng L; Sabichi AL; Blechacz B; Rashid A; Samaniego F Mol Cancer Res; 2015 May; 13(5):809-18. PubMed ID: 25678597 [TBL] [Abstract][Full Text] [Related]
8. HuR knockdown changes the oncogenic potential of oral cancer cells. Kakuguchi W; Kitamura T; Kuroshima T; Ishikawa M; Kitagawa Y; Totsuka Y; Shindoh M; Higashino F Mol Cancer Res; 2010 Apr; 8(4):520-8. PubMed ID: 20332213 [TBL] [Abstract][Full Text] [Related]
9. Androgen regulates the level and subcellular distribution of the AU-rich ribonucleic acid-binding protein HuR both in vitro and in vivo. Sheflin LG; Zhang W; Spaulding SW Endocrinology; 2001 Jun; 142(6):2361-8. PubMed ID: 11356683 [TBL] [Abstract][Full Text] [Related]
10. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes. Zhang M; Rao PV Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490 [TBL] [Abstract][Full Text] [Related]
11. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells. Guo X; Hartley RS Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells. Nagahara T; Okano J; Murawaki Y Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586 [TBL] [Abstract][Full Text] [Related]
13. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Young LE; Moore AE; Sokol L; Meisner-Kober N; Dixon DA Mol Cancer Res; 2012 Jan; 10(1):167-80. PubMed ID: 22049153 [TBL] [Abstract][Full Text] [Related]
14. Effects of E2F1-cyclin E1-E2 circuit down regulation in hepatocellular carcinoma cells. Farra R; Dapas B; Pozzato G; Scaggiante B; Agostini F; Zennaro C; Grassi M; Rosso N; Giansante C; Fiotti N; Grassi G Dig Liver Dis; 2011 Dec; 43(12):1006-14. PubMed ID: 21831731 [TBL] [Abstract][Full Text] [Related]
15. Loss of CARM1 is linked to reduced HuR function in replicative senescence. Pang L; Tian H; Chang N; Yi J; Xue L; Jiang B; Gorospe M; Zhang X; Wang W BMC Mol Biol; 2013 Jul; 14():15. PubMed ID: 23837869 [TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333 [TBL] [Abstract][Full Text] [Related]
17. Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression. Niesporek S; Kristiansen G; Thoma A; Weichert W; Noske A; Buckendahl AC; Jung K; Stephan C; Dietel M; Denkert C Int J Oncol; 2008 Feb; 32(2):341-7. PubMed ID: 18202756 [TBL] [Abstract][Full Text] [Related]
18. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line. Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479 [TBL] [Abstract][Full Text] [Related]
19. mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells. Bolognani F; Gallani AI; Sokol L; Baskin DS; Meisner-Kober N J Neurooncol; 2012 Feb; 106(3):531-42. PubMed ID: 21935689 [TBL] [Abstract][Full Text] [Related]
20. Effect of cytoskeleton inhibitors on deadhesion kinetics of HepG2 cells on biomimetic surface. Feng Z; Chen B; Tang SC; Liao K; Chen WN; Chan V Colloids Surf B Biointerfaces; 2010 Jan; 75(1):67-74. PubMed ID: 19720507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]